Helius Medical Technologies, Inc. Stock Prediction and Forecast [HSDT]

AI-generated source summary

The analysis of Helius Medical Technologies (HSDT) on September 12, 2025, indicates a strong buy candidate with a score of 5.767. A gain of 10.36% has been observed since September 10, 2025, resulting in an average return of 3.45% per day. Short-term trends suggest further upward movement. Over the next 3 months, a 39% change is anticipated, expected returns range between -42% and 132%. A 12-month analysis anticipates a change of -37%, potentially putting the future price ranging between 0 and $5.46. The latest trading day showed an increase of 3.14% to $7.56. The stock's volume rose, while exhibiting fluctuation by 23.89% trading between $7.20 and $8.92. There are several buy signals from moving averages are in place and we should consider short term supports from 6.53 and 6.40. MACD analysis also presents a buy signal. A sell signal from a pivot top was triggered 50 days ago. The recommended stop-loss is $7.15.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   13 Sept 2025, 04:24 UTC

   The analyst published the original source item.

2. First prediction resolved

   15 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   15 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:11 UTC

   Tahlil Plus began monitoring the extracted predictions.